Gorana Gašljević
- Biotechnology top 1%
- Microbial Inactivation Methods 14
- Biomedical Engineering top 10%
- Microfluidic and Bio-sensing Technologies 8
- Ultrasound and Hyperthermia Applications 4
-
- Viral-associated cancers and disorders 6
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 4
-
- Lymphoma Diagnosis and Treatment 15
-
- Chronic Lymphocytic Leukemia Research 8
- Co-authors
- Maja ČemažarGregor SeršaErik BreceljIbrahim EdhemovićBor KosDamijan MiklavčičEldar M. GadžijevMaja Marolt Mušič
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- SloveniaSwitzerlandItaly
In The Last Decade
Gorana Gašljević
41 papers receiving 609 citations
Peers
Comparison fields: 5 of 56
- Biotechnology 407
- Biomedical Engineering 308
- Immunology 129
- Physiology 22
- Oncology 97
Countries citing papers authored by Gorana Gašljević
This map shows the geographic impact of Gorana Gašljević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gorana Gašljević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gorana Gašljević more than expected).
Fields of papers citing papers by Gorana Gašljević
This network shows the impact of papers produced by Gorana Gašljević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gorana Gašljević. The network helps show where Gorana Gašljević may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gorana Gašljević, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 4 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 6 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 0 | |
| 14 | 2020 | 33 | |
| 15 | 2020 | 12 | |
| 16 | 2019 | 18 | |
| 17 | 2015 | 3 | |
| 18 | 2013 | 10 | |
| 19 | 2013 | 12 | |
| 20 | 2006 | 19 |
About Gorana Gašljević
Gorana Gašljević is a scholar working on Biotechnology, Pathology and Forensic Medicine and Oncology, having authored 51 papers that have together received 620 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Microbial Inactivation Methods (14 papers), Chronic Lymphocytic Leukemia Research (8 papers), Microfluidic and Bio-sensing Technologies (8 papers), Viral-associated cancers and disorders (6 papers), CAR-T cell therapy research (6 papers), Ultrasound and Hyperthermia Applications (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Biotechnology (407 citations), Biomedical Engineering (308 citations) and Immunology (129 citations). Gorana Gašljević has collaborated with scholars based in Slovenia, Switzerland and Italy. Frequent co-authors include Maja Čemažar, Gregor Serša, Erik Brecelj, Ibrahim Edhemović, Bor Kos, Damijan Miklavčič, Eldar M. Gadžijev, Maja Marolt Mušič, Marko Snoj and Tomaž Jarm. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.